North American Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast To 2025


Posted April 15, 2020 by rishabh3210

North American Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast To 2025North American Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast To 2025

 
The North American IBD market is estimated to grow significantly at a CAGR of around 4.8% during the forecast period. Rising prevalence and incidence of IBD across the region is the major driving factor for the market. Moreover, an increasing number of cigarette-smokers in the US and significant funding in the IBD field in Canada is further estimated to boost the market growth of the region. Furthermore, well-developed healthcare expenditure coupled with increased per capita healthcare expenditure across the region will support the market growth over the forecast period. Canada has among the highest reported prevalence and incidence rates of IBD across the globe.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-ibd-inflammatory-bowel-disease-market

North American IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. North American IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery.

A Full Report of North American Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/north-american-ibd-inflammatory-bowel-disease-market

The companies which are contributing to the growth of the North American IBD market include Abbott Laboratories, AbbVie Inc., Accesa Labs, Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others.

Market Segmentation

North American IBD Market by Disease Type

Ulcerative Colitis
Crohn’s Disease

North American IBD Market by Diagnostics

Blood and Stool Tests
Endoscopies,
Ultrasound
X-Ray

North American IBD Market by Therapeutics

Surgery
Anti- Inflammatory Drug Administration
Steroids
Immunosuppressant
Biological Drugs
Amino salicylates
Others

Regional Analysis

United States
Canada

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-ibd-inflammatory-bowel-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr. Anurag Tiwari
Phone +1 646-755-7667
Country India
Categories Business
Tags north american inflammatory bowel disease ibd market size , share forecast to 2025
Last Updated April 15, 2020